Your browser doesn't support javascript.
loading
LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer.
Hu, Ziming; Zheng, Xiaohu; Jiao, Defeng; Zhou, Yonggang; Sun, Rui; Wang, Baolong; Tian, Zhigang; Wei, Haiming.
Afiliación
  • Hu Z; CAS Key Laboratory of Innate Immunity and Chronic Disease and Institute of Immunology, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui 230027, China.
  • Zheng X; CAS Key Laboratory of Innate Immunity and Chronic Disease and Institute of Immunology, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui 230027, China.
  • Jiao D; CAS Key Laboratory of Innate Immunity and Chronic Disease and Institute of Immunology, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui 230027, China.
  • Zhou Y; Hefei National Laboratory for Physical Sciences at Microscale, University of Science and Technology of China, Hefei, Anhui 230027, China.
  • Sun R; CAS Key Laboratory of Innate Immunity and Chronic Disease and Institute of Immunology, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui 230027, China.
  • Wang B; CAS Key Laboratory of Innate Immunity and Chronic Disease and Institute of Immunology, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui 230027, China.
  • Tian Z; Hefei National Laboratory for Physical Sciences at Microscale, University of Science and Technology of China, Hefei, Anhui 230027, China.
  • Wei H; Department of Clinical Laboratory, Division of Life Sciences and Medicine, First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, 230001, China.
Mol Ther Oncolytics ; 17: 361-370, 2020 Jun 26.
Article en En | MEDLINE | ID: mdl-32405534

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Año: 2020 Tipo del documento: Article País de afiliación: China